CLBS - Caladrius Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $6.11. This is a potential upside of $6.11 (0%) from yesterday's end of day stock price of $0.

Caladrius Biosciences's activity chart (see below) currently has 7 price targets and 11 ratings on display.

Stock Analyst Price Targets - Review

Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 26-Apr-2022.

Best performing analysts who are covering CLBS - Caladrius Biosciences:

Joseph Pantginis Raghuram Selvaraju Jason Kolbert Keay Nakae Kumaraguru Raja

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

3 years 6 months 3 days ago
(26-Apr-2022)

0/2 (0%)

$13.85 (297.85%)

Buy

3 years 7 months 7 days ago
(22-Mar-2022)

0/1 (0%)

$9.52 (173.72%)

Buy

$7

$6.57 (1527.91%)

$7

4 years 7 months 27 days ago
(02-Mar-2021)

0/2 (0%)

$5.1 (268.42%)

Buy

$6

$5.57 (1295.35%)

6 years 7 months 15 days ago
(14-Mar-2019)

0/1 (0%)

$2.08 (53.06%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CLBS (Caladrius Biosciences) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CLBS (Caladrius Biosciences) with a proven track record?

JOSEPH PANTGINIS

Which analyst has the current lower performing score on CLBS (Caladrius Biosciences) with a proven track record?

KUMARAGURU RAJA

Which analyst has the most public recommendations on CLBS (Caladrius Biosciences)?

Joseph Pantginis has 28 price targets and 25 ratings on CLBS

Which analyst is the currently most bullish on CLBS (Caladrius Biosciences)?

Kumaraguru Raja with highest potential upside - $6.57

Which analyst is the currently most reserved on CLBS (Caladrius Biosciences)?

Joseph Pantginis with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?